Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of
chronic pulmonary infection, posing a number of challenges for both clinicians and …

Nontuberculous mycobacteria (NTM) are emerging pathogens that affect both
immunocompromised and immunocompetent patients. The incidence and prevalence of …

Mycobacterium abscessus (M. abscessus) is an opportunistic pathogen usually colonizing
abnormal lung airways and is often seen in patients with cystic fibrosis. Currently, there is no …

Abstract Background Mycobacterium abscessus and Mycobacterium massiliense are
grouped as the Mycobacterium abscessus complex. The aim of this study was to elucidate …

Mycobacterium abscessus (Mab), a nontuberculous mycobacterial (NTM) species, is an
emerging pathogen with high intrinsic drug resistance. Current standard-of-care therapy …

Patients with lung disease caused by Mycobacterium abscessus subsp. abscessus (here M.
abscessus) typically have poor treatment outcomes. Although clofazimine (CFZ) has been …

Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data
supporting effective drugs or dosing regimens are limited. To better identify treatment …

Introduction: Mycobacterium abscessus is an emerging mycobacteria that is responsible for
lung diseases and healthcare-associated extrapulmonary infections. Recent findings …

The mortality incidence from nontuberculous mycobacteria (NTM) infections has been
steadily developing globally. These bacterial agents were once thought to be innocent …

Nontuberculous mycobacteria (NTM) are ubiquitous organisms; their isolation from clinical
specimens does not always indicate clinical disease. The incidence of NTM lung diseases …